These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38249344)
1. Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials. Fan J; Li T; Pu F; Guo N; Wang J; Gao Y; Zhao H; Wang X; Zhu H Front Pharmacol; 2023; 14():1265766. PubMed ID: 38249344 [No Abstract] [Full Text] [Related]
2. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oral Chinese patent medicines in the treatment of coronary heart disease combined with hyperlipidemia: a systematic review and network meta-analysis of 78 trials. Yang Z; Li J; Zhou B; Ji X; Yuan J; Yan J; Nan X; Guo D Chin Med; 2023 Dec; 18(1):162. PubMed ID: 38093294 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis. Zhao J; Ai J; Mo C; Shi W; Meng L Complement Ther Med; 2022 Aug; 67():102831. PubMed ID: 35398481 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hui J; Yuan R; Li P; Xin Q; Miao Y; Shen X; Xu F; Cong W J Clin Med; 2022 May; 11(11):. PubMed ID: 35683377 [TBL] [Abstract][Full Text] [Related]
7. Chinese Herbal Medicines for Restenosis After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Wu J; Zhao L; Lin K; Lu L; Luo C J Altern Complement Med; 2019 Oct; 25(10):983-992. PubMed ID: 31464515 [No Abstract] [Full Text] [Related]
8. [Network Meta-analysis of oral Chinese patent medicines in treating type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease]. Zhang XM; Zhao XX; Liu Y; Xie YM Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5078-5090. PubMed ID: 37802850 [TBL] [Abstract][Full Text] [Related]
9. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481 [TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention]. Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis. Liu J; Zhang X; Xu G Front Pharmacol; 2022; 13():939488. PubMed ID: 36071841 [No Abstract] [Full Text] [Related]
12. The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials. Huang P; Li Z; Chen L; Zeng J; Zhao S; Tang Y; Huang B; Guan H; Chen Y; Feng Y; Lei S; Wu Q; Zhang H; Huang X; Zeng L; Liu Y; Zeng Z; Chen B Front Pharmacol; 2022; 13():918689. PubMed ID: 36059992 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of Chinese patent medicine in the adjuvant treatment of prostate cancer: A Bayesian network meta-analysis. Wang S; Zhang F; Liu J; Qin P Medicine (Baltimore); 2024 Mar; 103(12):e37180. PubMed ID: 38517994 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach. Rao Y; Wang Y; Lin Z; Zhang X; Ding X; Yang Y; Liu Z; Zhang B Front Cardiovasc Med; 2023; 10():1126110. PubMed ID: 37168657 [TBL] [Abstract][Full Text] [Related]
15. Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention. Zheng GH; Liu JP; Wang NS; Chen HY; Chu JF Evid Based Complement Alternat Med; 2012; 2012():253409. PubMed ID: 22454659 [TBL] [Abstract][Full Text] [Related]
16. [Network Meta-analysis of Qi-supplementing and Yin-nourishing Chinese patent medicines in treatment of early diabetic nephropathy]. Wang WR; Zhang XM; Li JX; Yang JY; Yu RH; Xie YM Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3949-3964. PubMed ID: 37475086 [TBL] [Abstract][Full Text] [Related]
17. [Network Meta-analysis of Chinese medicine injections in treatment of rheumatoid arthritis]. Liu S; Zhao XY; Li JF; Lu ZP; Zhang XG Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5627-5641. PubMed ID: 36471981 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta- analysis. Su W; Xie X; Zhao J; Fan Q; Dong N; Li Q; Du Y; Wu S Chin Med; 2023 Nov; 18(1):152. PubMed ID: 37986011 [TBL] [Abstract][Full Text] [Related]
19. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545 [TBL] [Abstract][Full Text] [Related]